What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Medical Device

Neurodegenerative Disease

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1697924

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1697924

Neuroplasticity Enhancement Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034

PUBLISHED: March 1, 2025

PAGES: 129 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The global neuroplasticity enhancement devices market size is expected to reach USD 71.40 billion by 2034, according to a new study by Polaris Market Research. The report "Neuroplasticity Enhancement Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type [Transcranial Magnetic Stimulation (TMS) Devices, Transcranial Direct Current Stimulation (tDCS) Devices, Electroencephalogram (EEG)-Based Devices, and Others], Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Neuroplasticity, the brain's ability to reorganize itself by forming new neural connections, has been a major focus in neuroscience, cognitive science, and medical research. In recent years, advancements in technology have led to the development of neuroplasticity enhancement devices, which aim to optimize brain function, accelerate learning, aid in rehabilitation, and even enhance cognitive abilities beyond natural limits. These devices use a variety of techniques, including electrical and magnetic stimulation, brainwave modulation, neurofeedback, and sensory augmentation, to encourage neuroplastic changes.

Transcranial magnetic stimulation (TMS) is a widely used device that employs magnetic fields to induce electric currents in the brain, facilitating neural reorganization. TMS has been approved for treating depression and has shown effectiveness in treating other neurological disorders, such as Parkinson's disease and chronic pain conditions.

These device allow users to monitor and regulate their brain activity in real time, providing a form of self-directed neuroplasticity training. Electroencephalography (EEG)-based neurofeedback devices track brainwave patterns and provide feedback through visual, auditory, or haptic cues, helping users train their brain activity toward desired states. Brain-computer interfaces (BCIs) are also playing a crucial role in neuroplasticity enhancement. BCIs have been particularly transformative for individuals affected by paralysis or neurodegenerative conditions, enabling them to regain functional independence.

Neuroplasticity Enhancement Devices Market Report Highlights

In terms of product type, the transcranial magnetic stimulation (TMS) devices segment held the largest neuroplasticity enhancement devices market share in 2024 due to their proven effectiveness in treating neurological and psychiatric disorders.

Based on end user, the home care settings segment is projected to hold a dominant share in the coming years as individuals seek convenient, cost-effective solutions for cognitive enhancement and neurological rehabilitation.

North America dominated the global neuroplasticity enhancement devices market revenue share in 2024 due to its strong healthcare infrastructure, high adoption of advanced neurotechnology, and increasing prevalence of neurological disorders.

The market in Asia Pacific is expected to grow in the coming years, owing to rapid urbanization, increasing healthcare expenditures, and growing awareness of the brain.

A few of the global key market players are BioSerenity; Blackrock Neurotech; BrainCo Inc.; BrainsWay; Ceribell, Inc.; EMOTIV; Flow Neuroscience; Neurable; Neuralink; NeuroPace, Inc.; Paradromics; and Synchron.

Polaris Market Research has segmented the neuroplasticity enhancement devices market report on the basis of product type, application, end user, and region:

By Product Type Outlook (Revenue, USD Billion, 2020-2034)

Transcranial Magnetic Stimulation (TMS) Devices
Transcranial Direct Current Stimulation (tDCS) Devices
Electroencephalogram (EEG)-Based Devices
Others

By Application Mode Outlook (Revenue, USD Billion, 2020-2034)

Cognitive Enhancement
Stroke & Traumatic Brain Injury Recovery
Mental Health & Neurological Disorders
Learning & Memory Improvement
Others

By End User Outlook (Revenue, USD Billion, 2020-2034)

Hospitals & Clinics
Research Institutions & Academic Centers
Home Care Settings
Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM5416

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Neuroplasticity Enhancement Devices Market Insights

4.1. Neuroplasticity Enhancement Devices Market - Market Snapshot
4.2. Neuroplasticity Enhancement Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Geriatric Population Globally
  - 4.2.1.2. Growing Prevalence of Depression Among Young Population
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost and lack of awareness
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Neuroplasticity Enhancement Devices Market Trends
4.6. Value Chain Analysis

5. Global Neuroplasticity Enhancement Devices Market, by Product Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
5.3. Transcranial Magnetic Stimulation (TMS) Devices
- 5.3.1. Global Neuroplasticity Enhancement Devices Market, by Transcranial Magnetic Stimulation (TMS) Devices, by Region, 2020-2034 (USD Billion)
5.4. Transcranial Direct Current Stimulation (tDCS) Devices
- 5.4.1. Global Neuroplasticity Enhancement Devices Market, by Transcranial Direct Current Stimulation (tDCS) Devices, by Region, 2020-2034 (USD Billion)
5.5. Electroencephalogram (EEG)-Based Devices
- 5.5.1. Global Neuroplasticity Enhancement Devices Market, by Electroencephalogram (EEG)-Based Devices, by Region, 2020-2034 (USD Billion)
5.6. Others
- 5.6.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Neuroplasticity Enhancement Devices Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
6.3. Cognitive Enhancement
- 6.3.1. Global Neuroplasticity Enhancement Devices Market, by Cognitive Enhancement, by Region, 2020-2034 (USD Billion)
6.4. Stroke & Traumatic Brain Injury Recovery
- 6.4.1. Global Neuroplasticity Enhancement Devices Market, by Stroke & Traumatic Brain Injury Recovery, by Region, 2020-2034 (USD Billion)
6.5. Mental Health & Neurological Disorders
- 6.5.1. Global Neuroplasticity Enhancement Devices Market, by Mental Health & Neurological Disorders, by Region, 2020-2034 (USD Billion)
6.6. Learning & Memory Improvement
- 6.6.1. Global Neuroplasticity Enhancement Devices Market, by Learning & Memory Improvement, by Region, 2020-2034 (USD Billion)
6.7. Others
- 6.7.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Neuroplasticity Enhancement Devices Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
7.3. Hospitals & Clinics
- 7.3.1. Global Neuroplasticity Enhancement Devices Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
7.4. Research Institutions & Academic Centers
- 7.4.1. Global Neuroplasticity Enhancement Devices Market, by Research Institutions & Academic Centers, by Region, 2020-2034 (USD Billion)
7.5. Home Care Settings
- 7.5.1. Global Neuroplasticity Enhancement Devices Market, by Home Care Settings, by Region, 2020-2034 (USD Billion)
7.6. Others
- 7.6.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Neuroplasticity Enhancement Devices Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Neuroplasticity Enhancement Devices Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Neuroplasticity Enhancement Devices Market - North America
- 8.3.1. North America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.3.4. Neuroplasticity Enhancement Devices Market - U.S.
  - 8.3.4.1. U.S.: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.3.5. Neuroplasticity Enhancement Devices Market - Canada
  - 8.3.5.1. Canada: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
8.4. Neuroplasticity Enhancement Devices Market - Europe
- 8.4.1. Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.4. Neuroplasticity Enhancement Devices Market - UK
  - 8.4.4.1. UK: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.5. Neuroplasticity Enhancement Devices Market - France
  - 8.4.5.1. France: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.6. Neuroplasticity Enhancement Devices Market - Germany
  - 8.4.6.1. Germany: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.7. Neuroplasticity Enhancement Devices Market - Italy
  - 8.4.7.1. Italy: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.8. Neuroplasticity Enhancement Devices Market - Spain
  - 8.4.8.1. Spain: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.9. Neuroplasticity Enhancement Devices Market - Netherlands
  - 8.4.9.1. Netherlands: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.10. Neuroplasticity Enhancement Devices Market - Russia
  - 8.4.10.1. Russia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.11. Neuroplasticity Enhancement Devices Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
8.5. Neuroplasticity Enhancement Devices Market - Asia Pacific
- 8.5.1. Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.4. Neuroplasticity Enhancement Devices Market - China
  - 8.5.4.1. China: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.5. Neuroplasticity Enhancement Devices Market - India
  - 8.5.5.1. India: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.6. Neuroplasticity Enhancement Devices Market - Malaysia
  - 8.5.6.1. Malaysia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.7. Neuroplasticity Enhancement Devices Market - Japan
  - 8.5.7.1. Japan: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.8. Neuroplasticity Enhancement Devices Market - Indonesia
  - 8.5.8.1. Indonesia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.9. Neuroplasticity Enhancement Devices Market - South Korea
  - 8.5.9.1. South Korea: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.10. Neuroplasticity Enhancement Devices Market - Australia
  - 8.5.10.1. Australia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.11. Neuroplasticity Enhancement Devices Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
8.6. Neuroplasticity Enhancement Devices Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.4. Neuroplasticity Enhancement Devices Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.5. Neuroplasticity Enhancement Devices Market - UAE
  - 8.6.5.1. UAE: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.6. Neuroplasticity Enhancement Devices Market - Israel
  - 8.6.6.1. Israel: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.7. Neuroplasticity Enhancement Devices Market - South Africa
  - 8.6.7.1. South Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.8. Neuroplasticity Enhancement Devices Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
8.7. Neuroplasticity Enhancement Devices Market - Latin America
- 8.7.1. Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.4. Neuroplasticity Enhancement Devices Market - Mexico
  - 8.7.4.1. Mexico: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.5. Neuroplasticity Enhancement Devices Market - Brazil
  - 8.7.5.1. Brazil: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.6. Neuroplasticity Enhancement Devices Market - Argentina
  - 8.7.6.1. Argentina: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.7. Neuroplasticity Enhancement Devices Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. BioSerenity
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Blackrock Neurotech
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. BrainCo Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. BrainsWay
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Ceribell, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. EMOTIV
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Flow Neuroscience
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Neurable
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Neuralink
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. NeuroPace, Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Paradromics
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Synchron
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development

Product Code: PM5416

List of Tables:

Table 1 Global Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 2 Global Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 3 Global Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 4 North America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 5 North America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 6 North America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 7 U.S.: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 8 U.S.: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 9 U.S.: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 10 Canada: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 11 Canada: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 12 Canada: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 13 Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 14 Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 15 Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 16 UK: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 17 UK: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 18 UK: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 19 France: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 20 France: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 21 France: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 22 Germany: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 23 Germany: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 24 Germany: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 25 Italy: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 26 Italy: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 27 Italy: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 28 Spain: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 29 Spain: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 30 Spain: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 31 Netherlands: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 32 Netherlands: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 33 Netherlands: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 34 Russia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 35 Russia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 36 Russia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 37 Rest of Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 38 Rest of Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 39 Rest of Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 40 Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 41 Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 42 Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 43 China: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 44 China: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 45 China: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 46 India: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 47 India: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 48 India: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 49 Malaysia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 50 Malaysia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 51 Malaysia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 52 Japan: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 53 Japan: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 54 Japan: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 55 Indonesia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 56 Indonesia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 57 Indonesia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 58 South Korea: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 59 South Korea: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 60 South Korea: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 61 Australia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 62 Australia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 63 Australia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 64 Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 65 Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 66 Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 67 Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 68 Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 69 Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 70 Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 71 Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 72 Saudi Arabia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 73 UAE: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 74 UAE: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 75 UAE: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 76 Israel: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 77 Israel: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 78 Israel: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 79 South Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 80 South Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 81 South Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 82 Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 83 Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 84 Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 85 Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 86 Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 87 Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 88 Mexico: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 89 Mexico: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 90 Mexico: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 91 Brazil: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 92 Brazil: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 93 Brazil: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 94 Argentina: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 95 Argentina: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 96 Argentina: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
Table 97 Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
Table 98 Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
Table 99 Rest of Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Neuroplasticity Enhancement Devices Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Product Type
Figure 7. Global Neuroplasticity Enhancement Devices Market, by Product Type, 2024 & 2034 (USD Billion)
Figure 8. Market by Application
Figure 9. Global Neuroplasticity Enhancement Devices Market, by Application, 2024 & 2034 (USD Billion)
Figure 10. Market by End User
Figure 11. Global Neuroplasticity Enhancement Devices Market, by End User, 2024 & 2034 (USD Billion)